« Back
Home /
Iniparib (BSI-201)

Iniparib (BSI-201)

Item no.	S1087-10mM
Manufacturer	Selleckchem
CASRN	160003-66-7
Amount	10 mM/1 mL
Quantity options	10 mg 1 g 10 g 10 mM/1 mL 200 mg 50 mg 5 g
Category	Oncology Inhibitors & Compound Libraries Small Molecules By Organ Breast Cancer
Type	Inhibitors
Specific against	other
Smiles	C1=CC(=C(C=C1C(=O)N)[N+](=O)[O-])I
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	NSC-746045,IND-71677
Similar products	160003-66-7
Available
Storage Conditions	2 years -80 in solvent
Information	Iniparib (BSI-201, NSC-746045, IND-71677) is a PARP1 inhibitor with demonstrated effectiveness in triple-negative breast cancer (TNBC). Phase 3.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

S1087-10mM-datasheet.pdf

S1087-10mM-safety-datasheet.pdf